Loading stock data...

Chemo Pharma Laboratories Limited

BSE: CHEMOPH

BSE
130.85 0.00 (0.00%)

Prev Close

130.85

Open Price

116

Volume

766

Today Low / High

115 / 134.95

52 WK Low / High

63.05 / 152

Range

124 - 137

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 130.85, reflecting a change of 0 (0%). The expected target range on the BSE is 124 - 137. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

19 Nov 118.00 -5.34%
18 Nov 123.90 -4.76%
17 Nov 112.50 -0.36%
14 Nov 124.90 -0.48%
12 Nov 132.00 -5.30%
11 Nov 113.20 9.54%
10 Nov 129.00 -10.47%
07 Nov 115.70 0.26%
06 Nov 135.15 -12.65%
04 Nov 123.15 0.00%
03 Nov 131.50 -5.89%
31 Oct 116.00 12.80%
30 Oct 115.05 1.13%
28 Oct 112.60 9.37%

Chemo Pharma Laboratories Limited Graph

Chemo Pharma Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Chemo Pharma Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 130.85, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 130.85 132.16 118.94 - 145.37
133.47 106.77 - 160.16
134.78 94.34 - 175.21
Bearish Scenario 130.85 129.54 116.59 - 142.50
128.23 102.59 - 153.88
126.92 88.85 - 165.00

Overview of Chemo Pharma Laboratories Limited

ISIN

INE320M01019

Industry

Medical - Pharmaceuticals

Vol.Avg

550

Market Cap

196,275,000

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

136.61

DCF

-6

Financial Ratios Every Investor Needs

Stock Rating Details for CHEMOPH

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.62 Cr 0.00 Cr 0.62 Cr 0.9964 0.00 Cr 0.02 Cr 0.59 Cr 0.34 Cr 2.28 0.50 Cr 0.5521
2024-03-31 1.84 Cr 0.00 Cr 1.84 Cr 1.0000 0.00 Cr 0.17 Cr 1.64 Cr 1.20 Cr 8.00 1.65 Cr 0.6530
2023-03-31 0.30 Cr 0.00 Cr 0.29 Cr 0.9982 0.00 Cr 0.03 Cr 0.21 Cr 0.05 Cr 0.32 0.10 Cr 0.1603
2022-03-31 0.79 Cr 0.00 Cr 0.79 Cr 0.9989 0.00 Cr 0.12 Cr 0.61 Cr 0.56 Cr 3.73 0.27 Cr 0.7098
2021-03-31 0.55 Cr 0.00 Cr 0.55 Cr 0.9957 0.00 Cr 0.03 Cr 0.41 Cr 0.25 Cr 1.67 0.39 Cr 0.4561

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 10.62 Cr 13.35 Cr 0.21 Cr 13.1446 Cr 0.00 Cr -10.62 Cr 0.00 Cr 0.01 Cr 0.00 Cr 0.00 Cr 0.01 Cr 0.2052 Cr
2024-03-31 0.61 Cr 13.02 Cr 0.21 Cr 12.8024 Cr 0.00 Cr -0.61 Cr 0.00 Cr 0.02 Cr 0.00 Cr 0.00 Cr -1.10 Cr 0.1781 Cr
2023-03-31 0.56 Cr 11.62 Cr 0.02 Cr 11.6020 Cr 0.00 Cr -0.56 Cr 0.00 Cr 0.03 Cr 0.00 Cr 0.00 Cr -2.47 Cr 0.0200 Cr
2022-03-31 0.69 Cr 11.66 Cr 0.11 Cr 11.5547 Cr 0.00 Cr -0.69 Cr 0.00 Cr 0.04 Cr 0.00 Cr 0.00 Cr -2.56 Cr 0.1083 Cr
2021-03-31 2.17 Cr 11.05 Cr 0.06 Cr 10.9948 Cr 0.00 Cr -2.17 Cr 0.00 Cr 0.05 Cr 0.00 Cr 0.00 Cr -8.66 Cr 0.0584 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -0.2825 Cr 10.4580 Cr -0.1586 Cr -0.2825 Cr 10.0170 Cr 10.6228 Cr 0.0000 Cr 0.4981 Cr -0.1586 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 0.7236 Cr -0.5248 Cr -0.1489 Cr 0.7236 Cr 0.0499 Cr 0.6058 Cr 0.0000 Cr 1.2004 Cr -0.1489 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 -0.6834 Cr 0.6297 Cr -0.0763 Cr -0.6834 Cr -0.1300 Cr 0.5558 Cr 0.0000 Cr -0.1480 Cr -0.0763 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 -0.3286 Cr 0.9677 Cr -2.1243 Cr -0.3286 Cr -1.4852 Cr 0.6859 Cr 0.0000 Cr 0.1378 Cr -2.1243 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 -0.4083 Cr -0.1857 Cr 1.9568 Cr -0.4083 Cr 1.3627 Cr 2.1711 Cr 0.0000 Cr 0.0198 Cr 1.9568 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 0.02 Cr 0.00 Cr 0.02 Cr 1.0000 -11.83 Cr -11.81 Cr -78.70 -11.80 Cr -569.9626
2025-03-31 -0.16 Cr 0.00 Cr -0.17 Cr 1.0135 -0.02 Cr -0.34 Cr -2.27 0.60 Cr 2.0700
2024-12-31 -0.15 Cr 0.00 Cr -0.15 Cr 1.0000 -0.17 Cr -0.17 Cr -1.17 -0.17 Cr 1.1747
2024-09-30 0.63 Cr 0.00 Cr 0.63 Cr 1.0000 0.61 Cr 0.61 Cr 4.07 0.61 Cr 0.9667
2024-06-30 0.30 Cr 0.00 Cr 0.30 Cr 1.0000 0.25 Cr 0.25 Cr 1.64 0.25 Cr 0.8171

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 10.62 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -13.14 Cr
2025-03-31 10.62 Cr 0.00 Cr 10.62 Cr 0.00 Cr 0.00 Cr 10.81 Cr 0.01 Cr 13.35 Cr 0.21 Cr
2024-12-31 0.00 Cr 0.00 Cr 6.75 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -13.66 Cr
2024-09-30 1.25 Cr 5.68 Cr 6.94 Cr 0.00 Cr 0.00 Cr 6.95 Cr 0.02 Cr 13.70 Cr 0.04 Cr
2024-06-30 -6.11 Cr 12.21 Cr 6.11 Cr 0.00 Cr 0.00 Cr 6.11 Cr 0.00 Cr 0.00 Cr -12.80 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 -11.81 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -0.34 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -0.17 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.61 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.25 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹767.40 ₹91,909,729,910.00 ₹138,681.00

Key Executives

Company Secretary & Compliance Officer
Mr. Aditya Agarwal

Gender: male

Year Born:

MD, Chief Executive Officer & Director
Mr. Ruchit Mehta

Gender: male

Year Born: 1990

Chief Financial Officer & Executive Director
Mr. Utsav Trivedi

Gender: male

Year Born: 1999

FAQs about Chemo Pharma Laboratories Limited

Who is the CEO of the company?

The CEO is Ruchit Mehta.

What is the current market price of the stock?

The current price is ₹130.85.

What is the 52-week price range?

The range is ₹63.05-152.

What is the market capitalization of the company?

The market capitalization is ₹19.63 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -1.68.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Chemo Pharma Laboratories Limited (ISIN: INE320M01019) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹19.63 crores and an average daily volume of 550 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.